Notably, the FOSL1 intronic enhancer is a component of a significantly bigger Super Enhancer (SE) region, which has been discovered through comprehensive genome-wide investigations in GBM [18,19], pancreatic, and colorectal cancer cells. The gene discussed is FOSL1; the disease is glioblastoma.